• LAST PRICE
    1.5100
  • TODAY'S CHANGE (%)
    Trending Up0.0300 (2.0270%)
  • Bid / Lots
    1.4300/ 50
  • Ask / Lots
    1.5500/ 5
  • Open / Previous Close
    1.4500 / 1.4800
  • Day Range
    Low 1.4300
    High 1.5950
  • 52 Week Range
    Low 0.6174
    High 4.8700
  • Volume
    1,266,332
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.48
TimeVolumeKPTI
09:32 ET328971.45
09:34 ET6861.47
09:36 ET2001.48
09:38 ET4921.47
09:41 ET23001.4999
09:43 ET326151.5002
09:45 ET173081.495
09:48 ET9001.49
09:50 ET191101.485
09:52 ET20161.47
09:56 ET30391.48
09:57 ET21721.49
09:59 ET1001.49
10:01 ET13501.49
10:03 ET48601.5
10:06 ET1001.49
10:08 ET21351.4905
10:10 ET20671.48
10:12 ET13001.48
10:14 ET1001.48
10:15 ET5001.485
10:17 ET17201.48
10:19 ET2001.485
10:21 ET9691.485
10:24 ET2001.49
10:26 ET1001.485
10:30 ET31901.5
10:32 ET15921.494
10:35 ET223701.5
10:37 ET4001.495
10:39 ET10001.495
10:44 ET1001.5
10:46 ET6191.495
10:48 ET12001.4995
10:50 ET397771.515
10:51 ET14271.515
10:53 ET15881.515
10:55 ET459171.535
10:57 ET5081.535
11:00 ET3501.535
11:02 ET77611.525
11:04 ET43591.523
11:06 ET86951.525
11:08 ET2001.525
11:09 ET1001.52
11:11 ET30001.5215
11:13 ET2501.53
11:15 ET265701.53
11:20 ET8001.5321
11:22 ET35671.5217
11:24 ET93211.54
11:26 ET9001.545
11:27 ET638791.58
11:29 ET154551.58
11:31 ET64001.575
11:33 ET71481.57
11:36 ET138281.5799
11:38 ET12001.573
11:40 ET117001.575
11:42 ET7001.58
11:45 ET78251.5625
11:47 ET17761.565
11:49 ET46681.57
11:54 ET46001.57
11:56 ET1161.5701
11:58 ET229481.57
12:00 ET85601.58
12:02 ET185411.59
12:03 ET135521.595
12:05 ET7781.5802
12:07 ET75121.585
12:09 ET57391.58
12:12 ET55621.585
12:14 ET1081.585
12:18 ET12001.58
12:20 ET19001.585
12:21 ET2001.58
12:23 ET68961.57
12:25 ET48821.57
12:27 ET3001.57
12:30 ET1001.57
12:32 ET652131.555
12:34 ET13571.555
12:38 ET28181.555
12:41 ET79991.555
12:50 ET1001.555
12:54 ET2001.55
12:56 ET9511.555
01:01 ET63571.55
01:03 ET14001.5525
01:06 ET6471.555
01:10 ET47001.56
01:12 ET53071.565
01:14 ET15901.5699
01:17 ET55001.56
01:19 ET2471.56
01:21 ET46991.56
01:24 ET5001.565
01:26 ET1001.56
01:28 ET29001.565
01:30 ET9691.5682
01:32 ET260161.575
01:33 ET1981.575
01:35 ET8001.58
01:37 ET118791.57
01:39 ET1001.5601
01:44 ET2001.57
01:48 ET6391.57
01:51 ET43421.555
01:53 ET3001.555
01:55 ET5001.555
01:57 ET20541.554
02:02 ET2751.55
02:04 ET3001.555
02:08 ET1001.55
02:13 ET113821.555
02:15 ET4001.55
02:24 ET6181.555
02:26 ET98651.55
02:27 ET3031.545
02:29 ET4001.545
02:31 ET15541.545
02:36 ET3001.54
02:38 ET4001.545
02:40 ET2001.545
02:42 ET1031.5426
02:44 ET10001.545
02:45 ET2001.545
02:47 ET1001.545
02:49 ET2601.545
02:51 ET25711.545
02:56 ET261201.56
02:58 ET56921.57
03:00 ET3001.5601
03:02 ET17801.57
03:05 ET2001.57
03:07 ET25091.5693
03:09 ET10001.56
03:14 ET1751.565
03:20 ET9501.57
03:21 ET7501.565
03:23 ET8591.56
03:25 ET10551.565
03:27 ET6001.565
03:30 ET53001.57
03:34 ET38501.565
03:36 ET4041.565
03:38 ET13901.5625
03:39 ET276441.54
03:41 ET280641.53
03:43 ET46261.525
03:45 ET198121.53
03:48 ET5311.525
03:50 ET65311.53
03:52 ET809321.5
03:54 ET532361.515
03:56 ET32701.52
03:57 ET518661.505
03:59 ET1243091.51
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKPTI
Karyopharm Therapeutics Inc
173.8M
-1.2x
---
United StatesFGEN
FibroGen Inc
232.1M
-0.8x
---
United StatesAGEN
Agenus Inc
243.0M
-0.8x
---
United StatesKMDA
Kamada Ltd
322.4M
31.9x
-22.48%
United StatesMCRB
Seres Therapeutics Inc
116.9M
-0.9x
---
United StatesSGMO
Sangamo Therapeutics Inc
136.0M
-0.5x
---
As of 2024-03-29

Company Information

Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. It is developing and commercializing small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1). Its lead asset, XPOVIO (selinexor), is marketed in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. The Company is engaged in evaluating selinexor in certain hematological and solid tumor malignancies, including multiple myeloma, endometrial cancer, mycosis fungoides (MF) and diffuse large B-cell lymphoma (DLBCL). The Company’s product candidate, eltanexor, oral SINE compound that, like selinexor, selectively blocks the nuclear export protein XPO1.

Contact Information

Headquarters
85 Wells AveNEWTON CENTER, MA, United States 02459-3298
Phone
617-658-0600
Fax
302-655-5049

Executives

President, Chief Executive Officer, Director
Richard Paulson
Chief Financial Officer, Executive Vice President, Treasurer
Michael Mason
Executive Vice President, Chief Commercial Officer
Sohanya Cheng
Senior Vice President - Strategy and Portfolio Management
Stuart Poulton
Senior Vice President, General Counsel, Secretary
Michael Mano

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$173.8M
Revenue (TTM)
$146.0M
Shares Outstanding
115.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.02
EPS
$-1.25
Book Value
$-1.19
P/E Ratio
-1.2x
Price/Sales (TTM)
1.2
Price/Cash Flow (TTM)
---
Operating Margin
-88.71%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.